Continuous subcutaneous levodopa/carbidopa infusion (ND0612) for patients with Parkinson's disease and motor fluctuations: A Phase 3, active-controlled study (BouNDless). - Stocchi, F.; Espay, A.; Albanese, A.; Ellenbogen, A.; Ferreira, J.J.; Giladi, N.; Gurevich, T.; Hassin-Baer, S.; Hernandez-Vara, J.; Isaacson, S.; Kieburtz, K.; LeWitt, P.; et al. (Parkinsonism & Related Disorders, 2024)